Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ABTX - Agribiotech -- Ignore unavailable to you. Want to Upgrade?

To: James Hutton who wrote (7232)	1/25/1999 3:44:00 PM
From: The Ox	Read Replies (1) \| Respond to of 8359

Here's the first of many to come: Savett Frutkin Podell & Ryan, P.C. Files Class Action Against AgriBioTech, Inc PHILADELPHIA--(BUSINESS WIRE)--Jan. 25, 1999--Savett Frutkin Podell & Ryan, P.C. hereby gives notice that a class action complaint has been filed in the United States District Court for the Southern District of New York on behalf of a Class of persons who purchased the common stock of AgriBioTech, Inc. (NASDAQ: ABTX) (AgriBioTech" or the "Company") at artificially inflated prices during the period October 8, 1998 through January 22, 1999 (the "Class Period") and who were damaged thereby. The Complaint alleges that defendants, AgriBioTech and its Chairman and Chief Executive Officer, Johnny R. Thomas, violated the federal securities laws (Section 10(b) and 20(a)of the Securities Exchange Act of 1934) by misrepresenting or failing to disclose material information about the status of AgriBioTech's efforts to find a buyer for the company, including the possible price range and time frame. As a result of defendants' false and misleading statements and omissions, the price of AgriBioTech's stock was artificially inflated during the Class Period. On January 22, 1999, after the close of trading, the Company announced that it had abandoned its efforts to find a buyer and would only continue to make acquisitions on an "opportunistic basis." Savett Frutkin Podell & Ryan, P.C. has extensive experience representing shareholders in class actions and has successfully recovered hundreds of millions of dollars for defrauded investors and shareholders. The reputation and expertise of the firm in shareholder and other class action litigation has been repeatedly recognized by the courts, which have appointed the firm to major positions in complex class action litigations. Any member of the proposed Class who desires to be appointed lead plaintiff in this action must file a motion with the Court no later than sixty (60) days from January 25, 1999 or March 26, 1999. Class members must meet certain legal requirements to serve as a lead plaintiff. If you purchased AgriBioTech (ABTX) stock during the Class Period or have questions or information regarding this action or your rights, you may call or write: CONTACT: Barbara A. Podell, Esquire SAVETT FRUTKIN PODELL & RYAN, P.C. 325 Chestnut Street, Suite 700 Philadelphia, PA 19106 Telephone: 800/993-3233 E-mail: sfprpc@op.net CONTACT: Savett Frutkin Podell & Ryan, P.C. Barbara A. Podell, Esquire Telephone: 800/993-3233 E-mail: sfprpc@op.net

To: James Hutton who wrote (7232)	1/25/1999 4:00:00 PM
From: MoneyMade	Respond to of 8359

I'm buying bigtime...good luck 3 min. left!!! M$ney

To: James Hutton who wrote (7232)	1/25/1999 6:44:00 PM
From: W Shakespeare	Read Replies (1) \| Respond to of 8359

My impressions after the conference call: 1.) The big players in the industry are not impressed with ABTX as it currently stands. There will be no buy in until the company can integrate its acquisitions and create some genetically enhanced products (1-2 years away at best). It is incredible to me that management had the gall to say that negotiations would continue in private. Give it up! No sane individual would believe that a reasonable buy in is in the near future. 2.) The company no longer has the resources to continue acquisitions in the industry. Once again, management waffled on this point. There is no cash and no high stock price to acquire anything. I, for one, am glad. The company needs to tend to integration and leave acquisitions alone. 3.) The company's balance sheet is OK. There are no outstanding accounting issues with the SEC. 4.) The company's research program is progressing. This is the main reason I bought more today. IMHO, this company's stock price is undervalued relative to its long-term potential. 5.) Management needs to shut up and let its actions speak. This was one of the worst performances by management in a conference call I have ever heard. Even softly lobbed questions by analysts were dropped with a thud. I hope that management stays on course with its long-term strategic plan. I don't think that the street understands the potential of the sector. I also own MTC and no one seems to give any heed to their tremendous agricultural pipeline. ABTX is going to be dead money for a while. Perhaps we'll see a dead cat bounce followed by a gradual decline to lower levels. But the long-term outlook is still incredible. I remain a long-term shareholder.